Impact of Microbiota and Metabolites on Intestinal Integrity and Inflammation in Severe Obesity.

Custers, Emma; Vreeken, Debby; Schuren, Frank; van den Broek, Tim J.; van Dongen, Lieke; Geenen, Bram; de Blaauw, Ivo; Wiesmann, Maximilian; Hazebroek, Eric J.; Kleemann, Robert; Kiliaan, Amanda J.

Obesity is a multifactorial disease associated with low-grade inflammation. The gut is thought to be involved in obesity-related inflammation, as it is continuously exposed to antigens from food, microbiota and metabolites. However, the exact underlying mechanisms are still unknown. Therefore, we examined the relation between gut pathology, microbiota, its metabolites and cytokines in adults with severe obesity. Individuals eligible for bariatric surgery were included. Fecal and plasma samples were collected at surgery timepoint, to assess microbiota and metabolite composition. Jejunal biopsies were collected during surgery and stained for cytotoxic T cells, macrophages, mast cells and tight junction component zonula occludens-1. Based on these stainings, the cohort was divided into four groups: high versus low intestinal inflammation and high versus low intestinal integrity. We found no significant differences in microbiota diversity between groups, nor for individual bacterial species. No significant differences in metabolites were observed between the intestinal inflammatory groups. However, some metabolites and cytokines differed between the intestinal integrity groups. Higher plasma levels of interleukin-8 and tauro-chenodeoxycholic acid were found, whereas isovaleric acid and acetic acid were lower in the high intestinal integrity group. As the results were very subtle, we suggest that our cohort shows very early and minor intestinal pathology.

CYTOTOXIC T cells; GUT microbiome; TIGHT junctions; CELL junctions; MAST cells

Pharmaceuticals (14248247), 2024, Vol 17, Issue 7, p918

1424-8247

Academic Journal

10.3390/ph17070918